|
[1]
|
Zheng, R.S., Zhang, S.W., Zeng, H.M., et al. (2022) Cancer Incidence and Mortality in China, 2016. Journal of the Na-tional Cancer Center, 2, 1-9. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Yang, T., Xiong, Y., Zeng, Y., et al. (2022) Current Status of Immunotherapy for Non-Small Cell Lung Cancer. Frontiers in Pharmacology, 13, Article ID: 989461. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
张文谦, 李辉. 肺癌侵袭及转移机制的研究进展[J]. 中国临床新医学, 2022, 15(3): 198-201.
|
|
[4]
|
贾俊双, 孙妍, 肖东, 等. 慢病毒介导的外源基因体外投递系统的建立[J]. 热带医学杂志, 2008, 8(10): 1028-1029.
|
|
[5]
|
赵文淘, 赵尊兰, 史俊文, 等. 稳定过表达miR-26a肝癌细胞株的建立[J]. 热带医学杂志, 2013, 13(2): 140-142.
|
|
[6]
|
Boettcher, S., Miller, P.G., Sharma, R., et al. (2019) A Dominant-Negative Effect Drives Selection of TP53 Missense Mutations in Myeloid Malignancies. Science, 365, 599-604. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Yeh, P.Y., Yeh, K.H., Chuang, S.E., et al. (2004) Suppres-sion of MEK/ERK Signaling Pathway Enhances Cisplatin-Induced NF-kappaB Activation by Protein Phosphatase 4-Mediated NF-kappaB p65 Thr Dephosphorylation. Journal of Biological Chemistry, 279, 26143-26148. [Google Scholar] [CrossRef]
|
|
[8]
|
Qian, Z., Lin, C., Espinosa, R., et al. (2001) Cloning and Characteri-zation of MST4, a Novel Ste20-Like Kinase. Journal of Biological Chemistry, 276, 22439-22445. [Google Scholar] [CrossRef]
|
|
[9]
|
Lin, J.L., Chen, H.C., Fang, H.I., et al. (2001) MST4, a New Ste20-Related Kinase That Mediates Cell Growth and Transformation via Modulating ERK Pathway. Oncogene, 20, 6559-6569. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Hao, W.C., Zhong, Q.L., Pang, W.Q., et al. (2020) MST4 Inhibits Human Hepatocellular Carcinoma Cell Proliferation and Induces Cell Cycle Arrest via Suppression of PI3K/AKT Pathway. Journal of Cancer, 11, 5106-5117. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Han, X.M., Tian, P.Y., et al. (2019) MicroRNA-486-5p Inhibits Ovarian Granulosa Cell Proliferation and Participates in the Development of PCOS via Targeting MST4. European Review for Medical and Pharmacological Sciences, 23, 7217-7223.
|
|
[12]
|
Shi, Z., Jiao, S., Zhang, Z., et al. (2013) Structure of the MST4 in Complex with MO25 Provides Insights into Its Activation Mechanism. Structure, 21, 449-461. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Jiao, S., Zhang, Z., Li, C., et al. (2015) The Kinase MST4 Limits In-flammatory Responses through Direct Phosphorylation of the Adaptor TRAF6. Nature Immunology, 16, 246-257. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Caputo, M., Cansby, E., Kumari, S., et al. (2021) STE20-Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes. Hepatology Communications, 5, 1183-1200. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Ma, X., Zhao, H., Shan, J., et al. (2007) PDCD10 Interacts with Ste20-Related Kinase MST4 to Promote Cell Growth and Transformation via Modulation of the ERK Pathway. Molecu-lar Biology of the Cell, 18, 1965-1978. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Lin, Z.H., Wang, L., Zhang, J.B., et al. (2014) MST4 Promotes Hepatocellular Carcinoma Epithelial-Mesenchymal Transition and Metastasis via Activation of the p-ERK Pathway. In-ternational Journal of Oncology, 45, 629-640. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Wang, S.C., Lin, X.L., Li, J., et al. (2014) MicroRNA-122 Triggers Mesenchymal-Epithelial Transition and Suppresses Hepatocellular Carcinoma Cell Motility and Invasion by Targeting RhoA. PLOS ONE, 9, e101330. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
龙春庭, 邵敏, 陆小云. 激酶小分子抑制剂研究进展[J]. 药学学报, 2021, 56(2): 414-431.
|
|
[19]
|
Roskoski, R. (2022) Properties of FDA-Approved Small Molecule Protein Kinase Inhibitors: A 2022 Update. Pharmacological Research, 175, Article ID: 106037. [Google Scholar] [CrossRef] [PubMed]
|